Shares of Bone Biologics Corp. (BBLG) are currently gaining nearly 80% on Monday morning. Jeffrey Frelick, the company's president and chief executive officer, is set to present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 - 13, 2022.
BBLG is currently trading at $6.11, up $2.68 or 78.13%, on the Nasdaq, on a heavy volume of 31 million shares, above average volume of 565 thousand shares.
Bone Biologics is a medical device company that focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.